Article
The utility of homologous recombination deficiency biomarkers across cancer types
2021-02-20
Abstract excerpt
<h4>Background</h4> Genomic alterations in BRCA1/2 and genomic scar signatures are associated with homologous recombination DNA repair deficiency (HRD) and serve as therapeutic biomarkers for platinum and PARP inhibitors in breast and ovarian cancers. However, the clinical significance of these biomarkers in other homologous recombination repair-related genes or other cancer types is not fully understood. <h4>Resu...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 389ccddb-703f-5ae8-ac24-80984167b8f6
- DOI
- 10.1101/2021.02.18.21251882
